Skip to page content
Text size:  a A A

Leave Comment for Draft Research Plan

Draft Research Plan for Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication, 2022

This opportunity for public comment expires on February 26, 2020 8:00 PM EST.

The U.S. Preventive Services Task Force (USPSTF) welcomes you to the public comments page. The USPSTF is seeking comments to help make its draft documents more useful to primary care providers and others who are interested.


  • If you use the "Back" button on your browser or navigate away from this form, you will lose your comments.
  • You need to complete your comments in one session. It is not possible for comments to be saved and reopened.
  • Open-ended commentary fields in this form have a 4,000 character limit.


Confidentiality/Disclosure Policy (required)

Your comments will be handled on a confidential basis. We will not disclose, give, sell, or transfer any personal information about visitors to this Web site unless required by law enforcement or statute. You are not required to provide personal information to comment on this draft.

Acceptance of this Confidentiality/Disclosure Policy is required to submit your comments.